Fundraising FoxMagnusmedical
1 known investors
Find your way into Magnusmedical
Sign up to see every warm intro you have to Magnusmedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Magnusmedical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Magnus Medical develops SAINT, an FDA-cleared, noninvasive TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, in an accelerated 5-day course. The therapy, developed at Stanford's Brain Stimulation Lab, is offered to patients through verified clinical providers.
Investors · 1
Frequently asked questions
- What does Magnusmedical do?
- Magnus Medical develops SAINT, an FDA-cleared, noninvasive TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, in an accelerated 5-day course. The therapy, developed at Stanford's Brain Stimulation Lab, is offered to patients through verified clinical providers.
- Who are Magnusmedical's investors?
- Magnusmedical's investors include Awareness Venture.